Cargando…
Luteolin Potentially Treating Prostate Cancer and COVID-19 Analyzed by the Bioinformatics Approach: Clinical Findings and Drug Targets
Coronavirus disease 2019 (COVID-19) is a serious epidemic, characterized by potential mutation and can bring about poor vaccine efficiency. It is evidenced that patients with malignancies, including prostate cancer (PC), may be highly vulnerable to the SARS-CoV-2 infection. Currently, there are no e...
Autores principales: | Ye, Yu, Huang, Ziyan, Chen, Manying, Mo, Yongfeng, Mo, Zengnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844187/ https://www.ncbi.nlm.nih.gov/pubmed/35178029 http://dx.doi.org/10.3389/fendo.2021.802447 |
Ejemplares similares
-
Pueraria lobata Potentially Treating Prostate Cancer on Single-Cell Level by Network Pharmacology and AutoDock: Clinical Findings and Drug Targets
por: Mo, Yongfeng, et al.
Publicado: (2022) -
Mechanism and Experimental Verification of Luteolin for the Treatment of Osteoporosis Based on Network Pharmacology
por: Liang, Guihong, et al.
Publicado: (2022) -
Bioinformatics and In Silico Findings Uncover Bio-Targets of Calycosin Against Heart Failure and Diabetes Mellitus
por: Xu, Hongyuan, et al.
Publicado: (2022) -
The Mechanisms of Luteolin in Treating COVID-19 Based on Bioinformatics Analysis and Molecular Docking
por: Rong, Hechen, et al.
Publicado: (2023) -
Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto’s thyroiditis using bioinformatics methods
por: Liu, Ting-ting, et al.
Publicado: (2023)